Home > Healthcare > Medical Devices > Therapeutic Devices > Nasal Packing Devices Market

Nasal Packing Devices Market Share

Report ID: GMI9472
Published Date: May 2024
Report Format: PDF

Download Free Sample

Nasal Packing Devices Market Share

The market is highly competitive, with numerous manufacturers competing for market share. Key players often engage in product differentiation, innovation, and strategic partnerships to gain a competitive edge. Additionally, the presence of both established companies and smaller startups contributes to competitive intensity in the market. Therefore, the market exhibits a dynamic, competitive, and innovation-driven nature, shaped by regulatory requirements, technological advancements, clinical practices, and patient-centric considerations.

Nasal Packing Devices Market Companies

Some of the eminent market participants operating in the industry include:

Aegis Lifesciences
Fannin Limited
Boston Medical Products Inc.
INNOVIA MEDICAL
Aegis Lifesciences
Boston Medical Products Inc.
Cook
FABCO
Fannin Limited
INNOVIA MEDICAL
Lohmann & Rauscher GmbH & Co. KG
Medtronic plc
Meril Life Sciences Pvt. Ltd.
Network Medical Products Ltd.
Olympus Corporation
Smith & Nephew plc
Stryker Corporation
Summit Medical LLC.
Teleflex Incorporated

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Industry size for nasal packing devices was worth over USD 190.7 million in 2023 and is projected to expand at 5.2% CAGR from 2024 to 2032, owing to the rising prevalence of nasal conditions, such as chronic sinusitis, nasal trauma, and nasal tumors.

The injectables product segment in the nasal packing devices industry is projected to reach USD 67.8 million by 2032, due to their ability to offer targeted and controlled delivery of packing material directly into the nasal cavity.

The bioresorbable type segment in the nasal packing devices industry recorded USD 82.4 million in 2023, driven by their ability to provide temporary support and hemostasis within the nasal cavity following surgery or trauma.

U.S. industry is anticipated to record USD 107.5 million by 2032, led by the growing adoption of nasal implants, nasal surgeries, ongoing R&D efforts, and the integration of advanced technologies.